迈瑞医疗：体外诊断市场占有率持续提升

Core Viewpoint - The company has successfully increased its market share in the in vitro diagnostics (IVD) sector while maintaining stable gross margins, thanks to its core technology and strategic responses to national procurement policies [1] Market Share and Procurement - Since the second half of 2021, the company has actively participated in multiple centralized procurement projects, leveraging its multi-product line advantage in the IVD field to expand market share [1] - The company's market ranking in the chemiluminescence business has improved to third place domestically, while its biochemical business has surpassed a 15% market share for the first time [1] - The company has successfully won multiple bids for high-value consumables in 2024, including ultrasound knives and laparoscopic anastomosis devices, breaking into top-tier hospitals [1] Profitability and Cost Management - The company has managed to maintain its gross margin despite increased market share, primarily due to its mastery of core technologies [1] - The company aims to reduce the cost of chemiluminescence reagents by at least 50% over three years through increased self-manufacturing of core raw materials [1] - The introduction of new high-end ultrasound devices has allowed the company to double the price compared to previous models due to significant improvements in image performance [1] Innovation and Marketing - The company's technological innovations are increasingly competitive with imported brands, with some products leading in technology, which accelerates the acquisition of high-end clients [1] - The strategy to increase the revenue share of flow-type businesses, such as IVD reagents and high-value consumables, is expected to positively impact future profitability [1] Employee Engagement and Management - The company conducts regular employee surveys to assess management effectiveness and drive improvements, with a participation rate of 92.64% in the latest survey [1] - Survey results indicate that 84.78% of employees are engaged, and 80.23% express overall recognition of the company's management, culture, and development [1] - Approximately 89.16% of employees are confident in the company's future development [1]